Organometallics
Article
4.7 Hz, 4-C of Py), 148.6 (s, o-C of Tip × 2), 152.5 (s, p-C of Tip),
165.8−166.4 (m, 2-C and 6-C of Py), 187.0 (d, J = 4.2 Hz, CO2 of
OAc), 190.9 (s, CO2 of OAc × 2). 31P{1H} NMR (162 MHz,
CDCl3): δ 34.1 (dd, JP−Rh = 143.5 and 2.1 Hz). HRMS (FAB+): m/z
calcd for C38H4535ClNO6PRh2, 883.0783 [M]+; found, 883.0797.
Synthesis of COMeCl. The compound was prepared by following
the synthetic procedure for CHCl, using Rh2(OAc)4 (0.177 g, 0.400
mmol, 1.0 equiv), LOMe (0.219 g, 0.416 mmol, 1.0 equiv), acetic acid
(16 mL), CHCl3 (40 mL), and saturated NH4Cl(aq) (50 mL).
Isolation by recrystallization gave the product as a green solid (0.270
g, 0.286 mmol, 72%). 1H NMR (400 MHz, CDCl3): δ 1.03 (d, J = 6.7
Hz, 6H, CH3 of iPr), 1.32 (d, J = 6.4 Hz, 6H, CH3 of iPr), 1.37 (s, 6H,
(s, CH3 of CH3CN), 21.8 (s, CH3 of iPr × 2), 23.2 (s, CH3 of OAc ×
2), 23.4 (d, J = 3.4 Hz, CH3 of OAc × 2), 24.0 (s, CH3 of Pr × 2),
i
26.7 (s, CH3 of iPr × 2), 31.4 (s, CH of iPr × 2), 34.8 (s, CH of iPr),
116.4 (s, CN of CH3CN), 121.9 (s, m-C of Tip × 2), 125.6 (s, ipso-C
of Tip), 126.1 (d, J = 55.9 Hz, ipso-C of Ph × 2), 129.6 (d, J = 11.3
Hz, m-C of Ph × 4), 130.1 (br s, 5-C of Py), 131.5−131.6 (m, 3-C of
Py), 132.8 (d, J = 2.6 Hz, p-C of Ph × 2), 133.7 (d, J = 10.5 Hz, o-C
of Ph × 4), 138.2 (d, J = 5.6 Hz, 4-C of Py), 149.0 (s, o-C of Tip × 2),
153.2 (s, p-C of Tip), 163.1 (d, J = 71.9 Hz, 2-C of Py), 165.6−165.7
(m, 6-C of Py), 187.8 (d, J = 3.8 Hz, CO2 of OAc), 192.0 (s, CO2 of
OAc × 2). 31P{1H} NMR (162 MHz, CDCl3): δ 30.1 (dd, JP−Rh
=
138.6 and 3.3 Hz). LRMS (FAB+) m/z calcd for C38H45NO6PRh2,
848 [M − CH3CN − BF4]+); found, 848. Anal. Calcd for
C40H48BF4N2O6PRh2·0.5CH2Cl2·H2O: C, 46.91; H, 4.96; N, 2.70.
Found: C, 46.98; H, 4.91; N, 2.53.
i
OAc), 1.40 (d, J = 6.9 Hz, 6H, CH3 of Pr), 2.09 (s, 3H, OAc), 2.30
i
(sep, J = 6.5 Hz, 2H, CH of Pr), 3.09 (sep, J = 6.5 Hz, 1H, CH of
iPr), 3.82 (s, 6H, OCH3), 6.92 (br d, J = 7.6 Hz, 4H, m-H of p-An),
7.32−7.36 (m, 3H, ArH), 7.46−7.48 (m, 1H, ArH), 7.50−7.55 (m,
4H, ArH), 7.78−7.82 (m, 1H, ArH). 13C{1H} NMR (101 MHz,
Synthesis of [CH(MeCN)][PF6]. The compound was prepared by
following the synthetic procedure for [CH(MeCN)][BF4] using CHCl
(0.106 g, 0.120 mmol, 1.0 equiv), AgPF6 (33.3 mg, 0.132 mmol, 1.1
equiv), and acetonitrile (3 mL). Isolation by recrystallization gave the
product as a blue solid (0.121 g, 0.117 mmol, 98%). Single crystals
suitable for X-ray crystallographic analysis were obtained by slow
diffusion of diethyl ether into a dichloromethane solution of
i
CDCl3): δ 22.2 (s, CH3 of Pr × 2), 23.1 (s, CH3 of OAc × 2), 23.7
(d, J = 4.2 Hz, CH3 of OAc), 24.1 (s, CH3 of iPr × 2), 26.5 (s, CH3 of
iPr × 2), 31.3 (s, CH of iPr × 2), 34.7 (s, CH of iPr), 55.5 (s, OCH3 ×
2), 114.3 (d, J = 12.3 Hz, o-C of p-An × 4), 119.3 (d, J = 62.0 Hz,
ipso-C of p-An × 2), 121.8 (s, m-C of Tip × 2), 127.8 (s, ipso-C of
Tip), 128.1−128.2 (m, 5-C of Py), 129.8−129.9 (m, 3-C of Py),
135.3 (d, J = 5.9 Hz, 4-C of Py), 136.1 (d, J = 11.8 Hz, o-C of p-An ×
4), 148.6 (s, o-C of Tip × 2), 152.5 (s, p-C of Tip), 162.2 (d, J = 2.8
Hz, p-C of p-An × 2), 166.2−167.3 (m, 6-C of Py), 167.1 (d, J = 65.3
Hz, 2-C of Py), 186.9 (d, J = 3.8 Hz, CO2 of OAc), 190.8 (s, CO2 of
1
[CH(MeCN)][PF6]. H NMR (400 MHz, CDCl3): δ 1.06 (d, J =
6.8 Hz, 6H, CH3 of iPr), 1.31 (d, J = 6.5 Hz, 6H, CH3 of iPr), 1.38−
1.40 (m, 12H, CH3 of iPr and OAc), 2.12 (s, 3H, OAc), 2.26 (sep, J =
6.5 Hz, 2H, CH of iPr), 2.37 (s, 3H, CH3CN), 3.09 (sep, J = 6.9 Hz,
i
1H, CH of Pr), 7.36−7.42 (m, 6H, ArH), 7.48−7.51 (m, 1H, ArH),
OAc × 2). 31P{1H} NMR (162 MHz, CDCl3): δ 32.2 (dd, JP−Rh
=
7.53−7.57 (m, 4H, ArH), 7.62−7.65 (m, 2H, ArH), 7.70−7.72 (m,
1H, ArH), 8.14−8.18 (m, 1H, ArH). 13C{1H} NMR (101 MHz,
CDCl3): δ 3.1 (s, CH3 of CH3CN), 21.8 (s, CH3 of iPr × 2), 23.3 (s,
CH3 of OAc × 2), 23.5 (d, J = 2.8 Hz, CH3 of OAc), 24.0 (s, CH3 of
iPr × 2), 26.7 (s, CH3 of iPr × 2), 31.5 (s, CH of iPr × 2), 34.8 (s, CH
of iPr), 116.3 (s, CN of CH3CN), 121.9 (s, m-C of Tip × 2), 125.7 (s,
ipso-C of Tip), 126.0 (d, J = 56.1 Hz, ipso-C of Ph × 2), 129.7 (d, J =
11.4 Hz, m-C of Ph × 4), 130.0 (br s, 5-C of Py), 131.5−131.6 (m, 3-
C of Py), 132.9 (d, J = 2.6 Hz, p-C of Ph × 2), 133.7 (d, J = 10.7 Hz,
o-C of Ph × 4), 138.1 (d, J = 5.9 Hz, 4-C of Py), 149.1 (s, o-C of Tip
× 2), 153.3 (s, p-C of Tip), 163.2 (d, J = 72.1 Hz, 2-C of Py), 165.7−
165.8 (m, 6-C of Py), 187.9 (d, J = 3.6 Hz, CO2 of OAc), 192.1 (s,
CO2 of OAc × 2). 31P{1H} NMR (162 MHz, CDCl3): δ −144.4 (sep,
JP−F = 712.2 Hz, PF6), 30.1 (dd, JP−Rh = 138.6 and 3.5 Hz). HRMS
(FAB+): m/z calcd for C38H45NO6PRh2, 848.1095 [M − CH3CN −
PF6]+; found, 848.1073. Anal. Calcd for C40H48F6N2O6P2Rh2·H2O: C,
45.64; H, 4.79; N, 2.66. Found: C, 45.53; H, 4.73; N, 2.47.
142.5 and 2.7 Hz). HRMS (FAB+): m/z calcd for
C40H4935ClNO8PRh2, 943.0994 [M]+; found, 943.1003.
Synthesis of CCF3Cl. The compound was prepared by following
the synthetic procedure for CHCl, using Rh2(OAc)4 (0.177 g, 0.400
mmol, 1.0 equiv), LCF3 (0.248 g, 0.412 mmol, 1.0 equiv), acetic acid
(16 mL), CHCl3 (40 mL), and saturated NH4Cl(aq) (50 mL).
Isolation by recrystallization gave the product as a green solid (0.267
g, 0.261 mmol, 65%). 1H NMR (400 MHz, CDCl3): δ 1.05 (d, J = 6.8
Hz, 6H, CH3 of iPr), 1.34 (d, J = 6.6 Hz, 6H, CH3 of iPr), 1.36 (s, 6H,
i
OAc), 1.41 (d, J = 6.9 Hz, 6H, CH3 of Pr), 2.11 (s, 3H, OAc), 2.26
i
(sep, J = 6.7 Hz, 2H, CH of Pr), 3.11 (sep, J = 6.9 Hz, 1H, CH of
iPr), 7.32−7.35 (m, 1H, ArH), 7.38 (s, 2H, m-H of Tip), 7.57−7.59
(m, 1H, ArH), 7.68−7.70 (m, 4H, ArH), 7.78−7.83 (m, 4H, ArH),
7.85−7.90 (m, 1H, ArH). 13C{1H} NMR (101 MHz, CDCl3): δ 22.1
i
(s, CH3 of Pr × 2), 23.3 (s, CH3 of OAc × 2), 23.7 (d, J = 3.9 Hz,
CH3 of OAc), 24.1 (s, CH3 of iPr × 2), 26.6 (s, CH3 of iPr × 2), 31.5
Synthesis of [CH(MeCN)][SbF6]. The compound was prepared by
following the synthetic procedure for [CH(MeCN)][BF4] using CHCl
(0.354 g, 0.400 mmol, 1.0 equiv), AgSbF6 (0.139 g, 0.404 mmol, 1.0
equiv), and acetonitrile (10 mL). Isolation by recrystallization gave
i
i
(s, CH of Pr × 2), 34.8 (s, CH of Pr), 122.0 (s, m-C of Tip × 2),
123.6 (q, J = 272.7 Hz, CF3 × 2), 125.6 (dq, J = 11.3 and 3.7 Hz, m-C
of p-CF3C6H4 × 4), 127.0 (s, ipso-C of Tip), 129.0 (br s, 5-C of Py),
130.1−130.2 (m, 3-C of Py), 132.6 (d, J = 54.1 Hz, ipso-C of p-
CF3C6H4 × 2), 133.8 (qd, J = 33.1 and 2.3 Hz, p-C of p-CF3C6H4 ×
2), 134.9 (d, J = 10.8 Hz, o-C of p-CF3C6H4), 135.8 (d, J = 4.8 Hz, 4-
C of Py), 148.6 (s, o-C of Tip × 2), 153.1 (s, p-C of Tip), 164.5 (d, J
= 67.2 Hz, 2-C of Py), 167.3−167.4 (m, 6-C of Py), 187.7 (d, J = 3.9
Hz, CO2 of OAc), 191.3 (s, CO2 of OAc × 2). 31P{1H} NMR (162
MHz, CDCl3): δ 35.1 (br d, JP−Rh = 145.5 Hz). HRMS (FAB+): m/z
calcd for C40H4437ClF6NO6PRh2, 1022.0580 [M + H]+; found,
1022.0608.
1
the product as a blue solid (0.437 g, 0.388 mmol, 97%). H NMR
(400 MHz, CDCl3): δ 1.06 (d, J = 6.8 Hz, 6H, CH3 of iPr), 1.31 (d, J
= 6.5 Hz, 6H, CH3 of iPr), 1.38−1.40 (m, 12H, CH3 of iPr and OAc),
2.12 (s, 3H, OAc), 2.27 (sep, J = 6.6 Hz, 2H, CH of iPr), 2.35 (s, 3H,
i
CH3CN), 3.09 (sep, J = 6.9 Hz, 1H, CH of Pr), 7.36−7.42 (m, 6H,
ArH), 7.46−7.49 (m, 1H, ArH), 7.53−7.57 (m, 4H, ArH), 7.62−7.66
(m, 2H, ArH), 7.69−7.70 (m, 1H, ArH), 8.09−8.13 (m, 1H, ArH).
13C{1H} NMR (101 MHz, CDCl3): δ 3.1 (s, CH3 of CH3CN), 21.8
Synthesis of [CH(MeCN)][BF4]. A solution of CHCl (0.106 g,
0.120 mmol, 1.0 equiv) and AgBF4 (25.3 mg, 0.130 mmol, 1.1 equiv)
in acetonitrile (3 mL) was stirred at room temperature for 1 h under
Ar. The resulting mixture was filtered through a pad of Celite. The
filtrate was evaporated to dryness, and the residue was recrystallized
from dichloromethane/diethyl ether to give the product as a blue
i
(s, CH3 of Pr × 2), 23.3 (s, CH3 of OAc × 2), 23.5 (d, J = 2.8 Hz,
CH3 of OAc), 24.1 (s, CH3 of iPr × 2), 26.7 (s, CH3 of iPr × 2), 31.5
i
i
(s, CH of Pr × 2), 34.8 (s, CH of Pr), 116.1 (s, CN of CH3CN),
121.9 (s, m-C of Tip × 2), 125.7 (s, ipso-C of Tip), 126.0 (d, J = 55.9
Hz, ipso-C of Ph × 2), 129.7 (d, J = 11.4 Hz, m-C of Ph × 4), 129.9
(br s, 5-C of Py), 131.4−131.5 (m, 3-C of Py), 132.9 (d, J = 2.7 Hz, p-
C of Ph × 2), 133.7 (d, J = 10.6 Hz, o-C of Ph × 4), 137.9 (d, J = 5.9
Hz, 4-C of Py), 149.1 (s, o-C of Tip × 2), 153.3 (s, p-C of Tip), 163.3
(d, J = 72.2 Hz, 2-C of Py), 165.8−165.9 (m, 6-C of Py), 187.9 (d, J =
3.5 Hz, CO2 of OAc), 192.1 (s, CO2 of OAc × 2). 31P{1H} NMR
(162 MHz, CDCl3): δ 30.1 (dd, JP−Rh = 138.5 and 3.6 Hz). HRMS
(FAB+): m/z calcd for C38H45NO6PRh2, 848.1095 [M − CH3CN −
SbF6]+; found, 848.1076. Anal. Calcd for C40H48F6N2O6PRh2Sb·
1
solid (0.114 g, 0.117 mmol, 98%). H NMR (400 MHz, CDCl3): δ
1.06 (d, J = 6.7 Hz, 6H, CH3 of iPr), 1.30 (d, J = 6.4 Hz, 6H, CH3 of
i
iPr), 1.38−1.40 (m, 12H, CH3 of Pr and OAc), 2.12 (s, 3H, OAc),
i
2.26 (sep, J = 6.5 Hz, 2H, CH of Pr), 2.41 (s, 3H, CH3CN), 3.09
(sep, J = 6.8 Hz, 1H, CH of iPr), 7.36−7.42 (m, 6H, ArH), 7.51−7.57
(m, 5H, ArH), 7.62−7.66 (m, 2H, ArH), 7.72−7.74 (m, 1H, ArH),
8.22−8.26 (m, 1H, ArH). 13C{1H} NMR (101 MHz, CDCl3): δ 3.1
2686
Organometallics 2021, 40, 2678−2690